Pediatrics
Brian Varisco, BS, MD (he/him/his)
Arkansas Childrens Hospital
Most clinical trials in critical care have failed to demonstrate significant differences between control and intervention arms. The historical lack of sophistication in separating patients by phenotype has likely limited discoverable differences of an intervention. The dynamic nature of critical illness mandates an approach based on how the disease evolves. Data show clinical and biologic heterogeneity across patients, even among similar phenotypic and demographic characteristics. Understanding biologic development (organ maturation, epigenetic modifications, senescence) may afford new possibilities for prognostic enrichment of targeted therapeutics. Speakers will describe emerging evidence from bench and bedside of differences across sex and age related to specific critical illness syndromes. Distinctions among neonate, toddler, school-age, and adolescent patients mandate a more personalized approach to pediatric critical illness. This session is relevant to audiences across the ages of critical illness, as well as surgeons and allied health professionals such as pharmacists and advanced practice nurses.
James L. Wynn, MD (he/him/his) – University of Florida
Sana J. Said, PharmD – Comer Children's Hospital
Dennis Simon, MD – Childrens Hospital of Pittsburgh of UPMC
Dana Fuhrman, DO, MS (she/her/hers) – Children's Hospital of Pittsburgh of UPMC